SCHEMBL514699

SCHEMBL514699

N#CC1CCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL514698 1.00
SCHEMBL4898301 1.00
Hydrochloric Acid SCHEMBL28324454 0.97
SCHEMBL4485360 0.92
SCHEMBL3065908 0.92
SCHEMBL17203423 0.85
SCHEMBL7129341 0.74
SCHEMBL23133728 0.72
SCHEMBL2573920 0.72
SCHEMBL37418 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112125891-A N2Selective tetrahydrofuran/tetrahydrothiophene substituted triazole derivative and synthesis method and application thereof 华东师范大学 2020-12-25 CN claimed
EP-2040824-A2 METHODS AND APPARATUS FOR THE ION MOBILITY BASED SEPARATION AND COLLECTION OF MOLECULES Excellims Corporation (US) 2009-04-01 EP claimed
US-20080173809-A1 METHODS AND APPARATUS FOR THE ION MOBILITY BASED SEPARATION AND COLLECTION OF MOLECULES EXCELLIMS CORPORATION (US) 2008-07-24 US claimed
WO-2008008826-A9 METHODS AND APPARATUS FOR THE ION MOBILITY BASED SEPARATION AND COLLECTION OF MOLECULES EXCELLIMS CORP (US) 2008-06-05 WO claimed
WO-2008008826-A2 METHODS AND APPARATUS FOR THE ION MOBILITY BASED SEPARATION AND COLLECTION OF MOLECULES EXCELLIMS CORPORATION (US) 2008-01-17 WO claimed
US-20260007672-A1 INHIBITORS OF MPTP NRG THERAPEUTICS LTD (GB) 2026-01-08 US disclosed
US-12491185-B2 Inhibitors of mPTP NRG THERAPEUTICS LTD (GB) 2025-12-09 US disclosed
EP-4652162-A1 INHIBITORS OF MPTP NRG Therapeutics LTD (GB) 2025-11-26 EP disclosed
US-20250177397-A1 INHIBITORS OF MPTP NRG THERAPEUTICS LTD (GB) 2025-06-05 US disclosed
CN-108348526-B Methods of treating arenaviridae and coronaviridae viral infections 吉利德科学公司 2025-04-25 CN disclosed
EP-4493573-A1 COMPOUNDS AND METHODS FOR TREATING DISEASE Rome Therapeutics, Inc. (US) 2025-01-22 EP disclosed
US-12187758-B2 Compounds and methods for treating disease ROME THERAPEUTICS, INC. (US) 2025-01-07 US disclosed
WO-2008008826-A2 METHODS AND APPARATUS FOR THE ION MOBILITY BASED SEPARATION AND COLLECTION OF MOLECULES EXCELLIMS CORPORATION (US) 2008-01-17 WO disclosed
EP-1780205-A1 METHOD FOR PRODUCING 3-AMINOMETHYLTETRAHYDROFURAN DERIVATIVE Mitsui Chemicals, Inc. (JP) 2007-05-02 EP disclosed
EP-1615899-A1 ALPHA-SUBSTITUTED CARBOXYLIC ACIDS AS PPAR MODULATORS PFIZER INC. (US) 2006-01-18 EP disclosed
US-20050234066-A1 Alpha substituted carboxylic acids AGOURON PHARMACEUTICALS, INC. 2005-10-20 US disclosed
US-20050187266-A1 Alpha substituted carboxylic acids PFIZER INC 2005-08-25 US disclosed
WO-2004092145-A1 ALPHA SUBSTITUTED CARBOXYLIC ACID AS PPAR MODULATORS PFIZER INC. (US) 2004-10-28 WO disclosed
JP-2003183267-A METHOD OF PREPARING OPTICALLY PURE (R)- OR (S)- TETRAHYDROFURANYL KETONE SK CORP 2003-07-03 JP disclosed
US-5648487-A ACARACIDES, INSECTICIDES CIBA-GEIGY CORPORATION (US) 1997-07-15 US disclosed